Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 10, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 24 November 2025 - 16:00

Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 10, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/reblozyl

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters